Cross-sector partnership launches EQBMED. Initially funded by PhRMA and established as a cross-sector collaborative, ...

Clinical trial processes lag behind scientific and technological advances. While the science and tools exist to run faster, more inclusive, and efficient trials, outdated mindsets, rigid protocols, ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...

Clinical research evolves to prioritize patient-centered outcomes, integrating accessibility standards in electronic data ...

Clinical trials face a critical challenge: bridging the gap between patient curiosity and motivation to participate, ...

Joint Clinical Assessment is now a parallel requirement under HTAR. Health technology developers must prepare for a JCA ...

New data from the POETYK PsA-Phase III trial, presented at the 2025 EULAR Congress, demonstrate that Bristol Myers Squibb’s Sotyktu (deucravacitinib) significantly improves joint and skin symptoms in ...

Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer Network (NCCN), shares insights on the complex barriers limiting cancer patient ...

As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...